Soligenix, logo

Soligenix, Share Price Today

(NASDAQ: SNGX)

Soligenix, share price is $2.27 & ₹197.42 as on 6 Mar 2025, 2.30 'hrs' IST

$2.27

0.07

(3.16%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Soligenix, share price in Dollar and Rupees. Guide to invest in Soligenix, stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Soligenix,, along with analyst recommendations, forecasts, and comprehensive financials.

Soligenix, share price movements

  • Today's Low: $2.14
    Today's High: $2.27

    Day's Volatility :5.6%

  • 52 Weeks Low: $1.83
    52 Weeks High: $14.92

    52 Weeks Volatility :87.73%

Soligenix, (SNGX) Returns

PeriodSoligenix Inc,Index (Russel 2000)
3 Months
-31.25%
0.0%
6 Months
-46.99%
0.0%
1 Year
-82.47%
0.0%
3 Years
-98.65%
-11.6%

Soligenix, (SNGX) Key Statistics

in dollars & INR

Previous Close
$2.2
Open
$2.2455
Today's High
$2.27
Today's Low
$2.1428
Market Capitalization
$5.5M
Today's Volume
$4.7K
52 Week High
$14.9184
52 Week Low
$1.8301
Revenue TTM
$364.2K
EBITDA
$-7.9M
Earnings Per Share (EPS)
$-6.4
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-139.8%

How to invest in Soligenix, Stock (SNGX) from India?

It is very easy for Indian residents to invest directly in Soligenix, from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Soligenix, stock in both Indian Rupees (INR) and US Dollars (USD). Search for Soligenix, or SNGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Soligenix, or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Soligenix, shares which would translate to 0.383 fractional shares of Soligenix, as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Soligenix,, in just a few clicks!

Returns in Soligenix, (SNGX) for Indian investors in Rupees

The Soligenix, stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Soligenix, investment value today

Current value as on today

₹23,050

Returns

₹76,950

(-76.95%)

Returns from Soligenix, Stock

₹81,912 (-81.91%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Soligenix, (SNGX)

-19%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Soligenix, Stock from India on INDmoney has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Soligenix,

  • Geode Capital Management, LLC

    1.04%

  • Morgan Stanley - Brokerage Accounts

    0.15%

  • UBS Group AG

    0.01%

  • Plante Moran Financial Advisors LP

    0.01%

Analyst Recommendation on Soligenix,

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Soligenix,(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Soligenix, Stock (SNGX)

What analysts predicted

Upside of 891.19%

Target:

$22.50

Current:

$2.27

Insights on Soligenix, Stock (Ticker Symbol: SNGX)

  • Price Movement

    In the last 6 months, SNGX stock has moved down by -47.0%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 244.81K → 2.34K (in $), with an average decrease of 75.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.64M → -1.71M (in $), with an average decrease of 4.6% per quarter
  • SNGX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 145.5%
  • SNGX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 146.3%
  • Price to Sales

    ForSNGX every $1 of sales, investors are willing to pay $7.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Soligenix, Technicals Summary

Sell

Neutral

Buy

Soligenix, is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Soligenix, (SNGX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Soligenix Inc, logo
-3.51%
-46.99%
-82.47%
-98.65%
-99.66%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Soligenix Inc, logo
NA
NA
-1.52
-7.1
-1.4
-0.45
NA
2.59
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Soligenix Inc, logo
Buy
$5.5M
-99.66%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Soligenix,

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX302, an IDR technology which is in Phase IIa study to treat mil-to-moderate Psoriasis; and SGX945 and IDR technology that is in Phase IIa protocol for the treatment of Aphthous Ulcers in Behçet's Disease. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia, Ib, and Ic clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.
Organization
Soligenix,
Employees
13
CEO
Dr. Christopher J. Schaber Ph.D.
Industry
Health Technology

Management People of Soligenix,

NameTitle
Dr. Christopher J. Schaber Ph.D.
Chairman of the Board of Directors, CEO & President
Mr. Jonathan L. Guarino CPA, CGMA
Senior VP, CFO & Corporate Secretary
Dr. Oreola Donini Ph.D.
Senior VP & Chief Scientific Officer
Dr. Richard C. Straube M.D., MSc.
Senior VP & Chief Medical Officer

Important FAQs about investing in SNGX Stock from India :

What is Soligenix, share price today?

Soligenix, share price today stands at $2.27, Open: $2.25 ; Previous Close: $2.20 ; High: $2.27 ; Low: $2.14 ; 52 Week High: $14.92 ; 52 Week Low: $1.83.

The stock opens at $2.25, after a previous close of $2.20. The stock reached a daily high of $2.27 and a low of $2.14, with a 52-week high of $14.92 and a 52-week low of $1.83.

Can Indians buy Soligenix, shares?

Yes, Indians can invest in the Soligenix, (SNGX) from India.

With INDmoney, you can buy Soligenix, at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Soligenix, at zero transaction cost.

How can I buy Soligenix, shares from India?

It is very easy to buy Soligenix, from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Soligenix, (SNGX) be purchased?

Yes, you can buy fractional shares of Soligenix, with INDmoney app.

What are the documents required to start investing in Soligenix, stocks?

To start investing in Soligenix,, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Soligenix, Stock (SNGX)?

Today’s highest price of Soligenix, (SNGX) is $2.27.

Today’s lowest price of Soligenix, (SNGX) is $2.14.

What is today's market capitalisation of Soligenix,?

Today's market capitalisation of Soligenix, SNGX is 5.5M

What is the 52 Week High and Low Range of Soligenix, Stock (SNGX)?

  • 52 Week High

    $14.92

  • 52 Week Low

    $1.83

What are the historical returns of Soligenix, (SNGX)?

  • 1 Month Returns

    -3.51%

  • 3 Months Returns

    -46.99%

  • 1 Year Returns

    -82.47%

  • 5 Years Returns

    -99.66%

Who is the Chief Executive Officer (CEO) of Soligenix, ?

Dr. Christopher J. Schaber Ph.D. is the current Chief Executive Officer (CEO) of Soligenix,.